Inicio › VIH › Texas › Houston
Ensayos clínicos de VIH en Houston, TX
17 estudios para VIH buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
ReclutandoEstudio observacional
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
ReclutandoFase 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Reclutando
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
ReclutandoFase 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · A 7 mi de distancia
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
ReclutandoFase 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
ReclutandoFase 1Se aceptan voluntarios sanos
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Reclutando
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Reclutando
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
ReclutandoSe aceptan voluntarios sanos
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
ReclutandoFase 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
ReclutandoFase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · A 7 mi de distancia
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Reclutando
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
ReclutandoFase 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Reclutando
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
ReclutandoFase 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
ReclutandoFase 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Más información sobre VIH en MedlinePlus
Ensayos de VIH en otras ciudades
- Washington, DC22 estudios
- New York City, NY19 estudios
- Miami, FL17 estudios
- Baltimore, MD16 estudios
- San Francisco, CA15 estudios
- Atlanta, GA14 estudios
- Chicago, IL14 estudios
- Boston, MA11 estudios
- Philadelphia, PA11 estudios
- San Diego, CA10 estudios
- Los Angeles, CA9 estudios
- Seattle, WA8 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas145 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)121 estudios
- Cáncer metastásico104 estudios
- Cáncer del colon y del recto102 estudios
- Cáncer de ovario89 estudios
- Leucemia mielógena aguda85 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata76 estudios
- Cáncer de endometrio68 estudios
- Cáncer de páncreas61 estudios
- Melanoma59 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.